(Total Views: 154)
Posted On: 10/02/2017 4:10:03 PM
Post# of 72446
Almost surreal walking into Q4 2017 with IPIX at $0.72 with B-OM results due this month and Prurisol/Kevetrin just around the corner. It seems the market does not grant much credence to Nerby's anecdotal P patient.
The PASI100 in the anectdotal is consistent with the prophecy. Georgii states that Prurisol is worth at least $10B and with a significant PASI100, as we saw in the mice, it indeed would be worth that. $10B is roughly $70/share fully diluted. These are not coincidences. The second leg of the prophecy (the return to $70 following a decline to $0.70) is going to come.
I'm a believer in Nerby, and the prophecy, and IPIX!
Go IPIX!
The PASI100 in the anectdotal is consistent with the prophecy. Georgii states that Prurisol is worth at least $10B and with a significant PASI100, as we saw in the mice, it indeed would be worth that. $10B is roughly $70/share fully diluted. These are not coincidences. The second leg of the prophecy (the return to $70 following a decline to $0.70) is going to come.
I'm a believer in Nerby, and the prophecy, and IPIX!
Go IPIX!
(2)
(0)
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.
